SUMMARY This paper describes the use of a panel of seven monoclonal antibodies (selected so as to include reagents reactive with both epithelial and lymphoid cells) for distinguishing between anaplastic carcinoma and high grade lymphoma. Details are given of the immunohistological reactions of these antibodies against a wide range of both normal and malignant tissues and of a number of practical instances in which use of the antibody panel enabled a diagnosis to be made when routine histological examination had been inconclusive.
For almost a century routine histopathological diagnosis has been based upon the examination of haematoxylin and eosin stained paraffin-embedded tissue sections, supplemented on occasion by the use of special stains such as the periodic acid-Schiff (PAS) reaction. Although the majority of tissues received in routine histopathology laboratories can be reliably diagnosed in this way, there are a number of cases in which a firm diagnosis cannot be made on morphological grounds alone.
One way to solve such diagnostic problems is to use immunohistological staining techniques. However until now this approach, although of genuine diagnostic value in occasional cases, has been limited in its scope by the relatively small number of tissue antigens which can be detected with currently available antisera. In consequence immunohistological staining techniques have remained a minority interest among pathologists, and play an insignificant role in the context of routine histopathological diagnosis.
The range of antigenic constituents which can be detected by immunohistological techniques in human Accepted for publication 29 March 1982 tissue has recently been dramatically expanded by the advent of monoclonal antibodies. Some of the human tissue antigens recognised by recently produced monoclonal antibodies have already been studied (albeit on a limited scale) using conventional antisera.
Other antibodies-for example, those identifying different T lymphocyte subclasses-represent valuable new cell markers which cannot be recognised with conventional antisera.
This increase in the number of detectable human tissue antigens suggests that immunohistological analysis of surgical biopsies using monoclonal antibodies may now come to play a greater role in the context of routine diagnosis. In the present paper we describe the use of a panel of monoclonal antibodies as probes for specific antigens (selected so as to include reagents reactive with both epithelial and lymphoid cells) to The staining reactions recorded in this Table refer to the malignant cells in each sample. As discussed in the text many HLA-DR and leucocyte-associated antigen positive cells were seen infiltrating most neoplasms. However, these reactions are not incorporated in this Table. "Patchy' indicates that only a small proportion of neoplastic cells were positive.
The two monoclonal anti-MFG antibodies showed a slight but distinct difference in their reactivity patterns, in that MFG-I reacted with smooth muscle in addition to epithelial cells, where MFG-2 showed no such reactivity. In all other respects however, the two antibodies gave identical staining patterns. This difference between the two antibodies is in keeping with observations by Arklie et al. 20 The explanation for this remains at present uncertain, particularly in view of the fact that the two antibodies are believed to be directed against the same molecule. shown in Fig. 7 immunohistological examination clearly showed the tumour to be a carcinoma most probably of primary colonic origin in view of CEA positivity. The patient died a few days after the operation, so that this diagnosis did not alter the management of this particular case.
Anaplastic tumour negative with all antibodies Case 5 in Table 4 illustrates a case which could not be unequivocally diagnosed using the panel of monoclonal antibodies although their use was, by exclusion, of some practical help. This patient was a 21-year-old man who presented initially with a tumour in one of his ribs. The histological diagnosis was of a diffuse non-Hodgkin's lymphoma and treatment with radiotherapy and chemotherapy was instituted. However, within a few months the patient returned with numerous lytic deposits in the bones of his skull. Biopsies of this recurrent tumour revealed a small cell anaplastic tumour, in which the cells were rich in glycogen, but could not be further defined.
Immunohistology was negative for all seven antibodies making a lymphoma or carcinoma unlikely (Fig. 8) . Although all the evidence now points to a Ewing's sarcoma this case highlights the fact that our current panel of antibodies is of limited value (because of the absence of positive reactions) in the analysis of sarcomatous tumours.
Discussion
This study has compared the reactivity patterns of a number of monoclonal antibodies with normal and neoplastic human tissues, and has illustrated the way in which human tumour samples which cannot be diagnosed with certainty on purely histological grounds may be categorised by immunohistological labelling using monoclonal antibodies (Table 5) . Before considering the implications of these findings for the practice of routine diagnostic histopathology the reaction pattern for individual antibodies detailed above may be reviewed in the context of previous studies.
HLA-DR (ANTIBODY CR3/43)
This antigen is the human homologue of the Ia-antigen of other species. Ia-antigen has been the subject of extensive study by transplantation immunologists because of its role in graft rejection.9 It is present not only on cells directly involved in the immune response-for example, B cells, activated T cells, Langerhans cells, dendritic cells-but also on a variety of epithelial cells. Expression by individual sections, with the consequence that intracytoplasmic HLA-DR antigen would be detectable as well as surface HLA-DR. This is relevant to a study'6 in which HLA-DR positivity was found in only 5% of carcinoma samples when analysing neoplastic cells in suspension (a technique which only allows the detection of cell surface antigens).
The variability in HLA-DR antigen expression characteristic of normal epithelial cells was also evident when studying carcinoma samples. It remains to be determined whether HLA-DR expression by human carcinoma is of any prognostic significance.
In contrast to the expression of HLA-DR by a proportion of carcinoma samples, the antigen was detectable in all of the diffuse B cell lymphoid neoplasms studied, in keeping with numerous previous studies of lymphoma. I '20 The present study has also confirmed the ubiquitous distribution in human tissue of the distinctive, irregularly shaped "dendritic" cells which stain strongly for HLA-DR. These cells have previously been most extensively studied in animals78 where they appear to have an as yet incompletely defined stimulatory role in certain immunological reactions-for example, the mixed leucocyte reaction .'
In summary therefore negative staining for HLA-DR on a tumour sample argues against the growth being of lymphoid origin-for example, case 2 in Table 4 . However, positive staining for this antigen is less informative since it may occur in both lymphoma and carcinoma samples.
MILK FAT GLOBULE ANTIGENS (ANTIBODIES MFG-I AND MFG-2) SPECIFICITY OF REACTION OF MFG-1 AND 2
These antibodies were raised against a delipidated preparation of the human milk fat globule and react with a component of the membrane which is not destroyed in formalin-fixed paraffin-embedded tissue.4 When tested by immunoperoxidase staining on sections of such tissues, the antibodies were found to react with lactating breast, primary breast carinomas and only to a very limited degree with resting normal breast.4 They did, however, show positive reactions with epithelial cells in some other exocrine glands or ducts and with renal tubules; the number and kind of tumours other than breast which were examined originally was limited, but ovary, lung and uterus appeared positive.
In the present investigation testing of acetone-fixed cryostat sections using the PAP technique revealed a somewhat wider range of tissues stained by these two antibodies. All normal glandular epithelia appeared to be positive, with the exception of prostate and liver. As might be expected from the spectrum of reaction with normal tissues, the MFG antibodies showed some positive reaction with most adenocarcinomas using the techniques for preparation and staining of tissue described here.
The reactions of MFG-1 and 2 resemble those reported by Sloane and Ormerod2' using a polyclonal antiserum raised by injecting rabbits with a delipidated preparation of the human milk fat globule. The major component recognised by this antiserum has been termed "epithelial membrane antigen", and it is likely that the monoclonal antibodies MFG-1 and 2 are recognising different epitopes on this or a similar component.
In summary the anti-MFG antibodies proved of value in confirming the epithelial origin of neoplasms, since lymphoid tissues consistently failed to react with these antibodies.
Cytokeratins are the group of proteins which make up the intermediate filaments of epithelial cells, and which are specific to these cells; thus they provide useful markers for epithelial cells in vitro and in vivo, as has already been demonstrated using polyclonal antisera.2223 This group of proteins is very heterogeneous and there are indications that subgroups, when suitably identified, will be useful in categorising tissues with greater specificity.2425 LE61 is a monoclonal antibody which was raised against cytokeratins of a marsupial kidney cell line' and it shows broad species cross-reactivity to a limited range of cytokeratin filaments. Its determinant has been referred to as a simple epithelium antigen (SEA)525 since it is restricted to the simple types of epithelia which do not form complex stratified squamous tissues and which will not normally become keratinised. The spectrum of reaction with human epithelial tissues and tumours is similar to, but wider than, that of the MFG antibodies.
The epidermal squamous carcinoma investigated here was negative with LE61 and the squamous lung carcinoma was positive; these two reactions are unchanged from those of the normal tissues from which the tumours were derived. It should be noted that neoplastic transformation, which generally results in a loss of some differentiated functions, can induce expression of cytokeratin SEA in normally negative stratified squamous epithelial cells (Lane, Leigh and Rupniak, manuscript in preparation). One should bear in mind that such phenotypic alteration could affect other monoclonal antibody determinants as well.
In summary the SEA cytokeratin filament antibody LE61 was of value in detecting carcinoma cells and distinguishing them from lymphoid neoplasms (which consistently failed to react with the cytokeratin antibody). A negative reaction does not however rule out an epithelial origin of a tumour, since keratinocyte-derived carcinomas may be either negative or positive.
KERATIN (ANTIBODY K92)
Keratin is an insoluble complex of intracellular proteins, consisting predominantly of cross-linked filament proteins (cytokeratin-related prekeratins)26, matrix proteins-for example, filaggrins26 and a highly cross-linked cell envelope protein (involucrin21). Keratin is produced by the distal layers of keratinocytes in stratified squamous epithelium of epidermis and its orifices and abnormally elsewhere-for example, some tumours. Of these three components, some but not all of the filamentous constituents appear to be common to all epithelia; filaggrin-like filament-associated proteins may also be found in other epithelia, but involucrin has so far only been found in keratinising epithelia, where it occurs in all but the basal layers of the tissue.
Conventional antisera raised against fully differentiated insoluble stratum corneum keratin28-30 usually contain a predominance of antifilament antibodies, and are generally widely cross-reactive with both squamous and glandular epithelia. The present study also represents an advance on previous immunohistological investigations of human neoplasms in that it was possible on several occasions (see Table 4 A comment should be made on the fact that all the immunohistological investigations reported in this paper were based upon the use of acetone-fixed cryostat sections of fresh frozen tissue. At first sight this may appear to impose a considerable restriction upon the application of monoclonal antibody immunohistology in routine histopathology laboratories. Not only does tissue have to be received and "cut up" within a short time of surgical removal, but there is also the inconvenience of freezing multiple routine samples and of being unable to perform retrospective studies on routine paraffin 1266 blocks. The question therefore arises of whether it might be possible to perform the labelling reactions described above on paraffin-embedded tissue, particularly in view of the fact that three of the antigens analysed in this study (keratin, CEA and the epithelial membrane antigen) have been studied in the past in paraffin-embedded tissue.
A full discussion of this topic is beyond the scope of this paper. However, in the authors' opinion the advantages of using cryostat sections greatly outweighs their disadvantages.
Firstly three of the antigens investigated (leucocyte-associated antigen, HLA-DR and cytokeratin filaments) lose their reactivity following formalin-fixation and paraffin-embedding. Many other antigens which can be recognised with recently developed,lmonoclonal antibodies also suffer in this way-for example, antigens specific for T cells and their sub-sets, surface membrane Ig etc. Furthermore, many of the antigens which will be detected in the future as new monoclonal antibodies become available will undoubtedly also be affected. Hence the great potential value of monoclonal antibody immunohistology as an adjunct to conventional histological examination will be greatly reduced if it is only applied to paraffin-embedded material.
Secondly it should be emphasised that the procedure for handling tissue sections (involving thorough drying after cutting and adequate fixation) leads to good preservation of tissue morphology. If immunoperoxidase-stained cryostat sections are examined in parallel with the routine haematoxylin and eosin stained paraffin section from a tumour there is no difficulty in discerning whether or not it is the malignant cell population which is labelled for an individual antigen.
In conclusion we suggest that the introduction of immunoperoxidase staining of cryostat sections using panels of selected monoclonal antibodies is an important improvement in diagnostic histopathology. The study reported in this paper provides only a very preliminary indication of the potential value of this approach, which is likely to become increasingly important as more monoclonal antibodies against tissue constituents become available.
